FOXR2 and neoplasm: Our findings reveal three mechanisms for aberrant FOXR2 activation in CNS tumors—promoter donation/enhancer hijacking through structural rearrangement, alternative promoter activation, and truncated LINE-1 retrotransposition, which showed differential preference among the various tumor types and anatomical sites.